The RITA-study -An Open Study to Evaluate the Blood Lipid Lowering Effect of Rosuvastatin Versus Fluvastatin and the Bilateral Interaction Between Everolimus and Rosuvastatin in Renal Transplant Recipients.

Trial Profile

The RITA-study -An Open Study to Evaluate the Blood Lipid Lowering Effect of Rosuvastatin Versus Fluvastatin and the Bilateral Interaction Between Everolimus and Rosuvastatin in Renal Transplant Recipients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Feb 2014

At a glance

  • Drugs Rosuvastatin (Primary) ; Everolimus; Fluvastatin
  • Indications Hypercholesterolaemia
  • Focus Pharmacokinetics; Therapeutic Use
  • Acronyms RITA
  • Most Recent Events

    • 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 24 Sep 2012 Planned End Date changed from 1 Sep 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov record.
    • 17 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top